Profile

Mercedes Porosnicu, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

56 Ratings

Mercedes Porosnicu, M.D.

Assistant Professor,


Clinical Specialties

Lung Cancer, Head and Neck Cancers

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-8664

Insurance Accepted »

Additional Languages

French, Romanian

Education & Training

  • M.D., Inst Medicine Lasi-Romania , 1987
  • Residency, Suny-Buffalo Affil Hosps, 1998
  • Fellowship, Hematology And Oncology, University of Miami, 2001
  • Fellowship, University of Miami, 2002
  • Fellowship, University of Miami, 2003

Memberships

  • Am Assn Of Cancer Research
  • Am Soc Of Clinical Oncology

NPI Number

  • 1417903584
Mercedes Porosnicu, M.D.

Doctor Rating

4.7 out of 5

56 Ratings

Mercedes Porosnicu, M.D.

Assistant Professor, Hematology & Oncology
Comprehensive Cancer Center
Translational Science Institute

Contact Information

Academic: 336-713-4392 | Department: 336-716-8664

Recent Publications

Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM. Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Porosnicu M, Liu J, Lyles D. Susceptibility of head and neck cancer to an attenuated model of the oncolytic vesicular stomatitis virus expressing suicide genes [abstract]. J Clin Oncol. 2010;27(15 Suppl):e14604.

Blackstock A, Petty J, Oaks T, Porosnicu M, Clark H, Lovato J, Miller A. Gefitinig (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. J Clin Oncol. 2007;25(18 Suppl):Abstr18165.

Blackstock AW, Jensen CA, Petty WJ, Oaks T, Porosnicu M, Clark H, Lovato JF, Miller A. Gefitinib (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage III NSCLC: a phase I study [abstract]. Int J Radiat Oncol Biol Phys. 2007;69(3 Suppl):S476.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Hematology & Oncology

Clinical Specialties

Lung Cancer, Head and Neck Cancers
Mercedes Porosnicu, M.D.

Mercedes Porosnicu, M.D.

Assistant Professor, Hematology & Oncology
Comprehensive Cancer Center
Translational Science Institute

Doctor Rating

4.7 out of 5

Mercedes Porosnicu, M.D.56 Ratings

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
3.9

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.